Development and in silico validation of the PID-algorithm for the artificial pancreas with intraperitoneal insulin delivery
Background: The efficacy of the treatment of type 1 diabetes can be markedly improved using artificial pancreas (AP), which is a technology to automatically control blood glucose levels. Aim: In this paper, we propose the construction of a controller for controlling the automated delivery of insuli...
Guardado en:
Autores principales: | Vladimir A. Karpelyev, Yury I. Philippov, Artem V. Averin, Maxim D. Boyarsky, Dmitriy A. Gavrilov |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bc4e861935e44709905fd92bbd72ef64 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Intraperitoneal insulin infusion: on the way to the artificial pancreas
por: Vladimir Aleksandrovich Karpel'ev, et al.
Publicado: (2015) -
De la bomba de insulina y el monitoreo continuo de glucosa al páncreas artificial
por: Apablaza,Pamela, et al.
Publicado: (2017) -
Free-living use of artificial pancreas for children with type 1 diabetes: systematic review
por: Klemen Dovc, et al.
Publicado: (2018) -
Overcoming marked insulin resistance in a patient with type 2 diabetes mellitus by means of insulin pumptherapy
por: Ekaterina Viktorovna Artemova, et al.
Publicado: (2012) -
Fatigue, mood, and sleep, during intraperitoneal chemotherapy: a pilot case control study
por: Heather Jim, et al.
Publicado: (2013)